AmorChem
Overview
AmorChem is a leading early-stage venture capital fund launched in 2011 in Montreal. The AmorChem team utilizes its deep understanding of fundamental science to uncover its therapeutic potential and focuses its core expertise in translational research to accelerate therapeutic drug discovery and development across a broad spectrum of disease areas. The fund capitalizes on both its venture capital expertise and its entrepreneurial experience to spark the creation of start-up companies and help shape them into the next generation of biotech companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kodikaz Therapeutic Solutions Inc. | May 2024 | VC Round | Co-investor |
| Immune Biosolutions | Mar 2021 | Series A | Co-investor |
| SemaThera Inc | Jan 2017 | Seed | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is AmorChem based?
AmorChem is headquartered in Quebec.
When was AmorChem founded?
AmorChem was founded in 2011.
How many portfolio companies does AmorChem have?
AmorChem has 4 portfolio companies in Caplight's dataset.
What are some companies in AmorChem's portfolio?
Portfolio companies visible on Caplight include Kodikaz Therapeutic Solutions Inc., Immune Biosolutions, SemaThera Inc.
What was AmorChem's most recent investment shown here?
AmorChem's most recent investment in this portfolio sample was in Kodikaz Therapeutic Solutions Inc. in 2024.
What sectors does AmorChem focus on?
AmorChem focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does AmorChem focus on?
AmorChem typically invests at the Early stage.